2021-22 | Reproductive Ethics in the Mexican Context
'Reproductive Ethics in the Mexican Context'
Knowledge Exchange Fellow:
Dr Cesar Palacios-Gonzalez | Faculty of Philosophy | University of Oxford
Instituto Nacional de Perinatología & Hospital Ángeles del Pedregal | Mr Raymundo Canales de la Fuente
Developments in assisted reproductive biotechnologies have dramatically expanded the ways in which we have biologically related children. Gone are the days where the only way in which to create a child necessarily involved intercourse. Currently, a couple can conceive outside the human body, via IVF, and the product can be gestated by a third party, via surrogacy. In the UK there is a longstanding tradition of academics who work on the ethical and legal issues surrounding assisted reproductive biotechnologies, and this work involves both academic activities traditionally understood, and engagement with policymakers and stakeholders. In Mexico, on the other hand, work on the ethical and legal issues surrounding assisted reproductive biotechnologies is nascent, and this presents exciting opportunities for collaboration with both academics who study these topics, from an ethical and legal perspective, and researchers and practitioners who specialise in reproductive medicine.
This knowledge exchange project will establish new relationships with Mexican physicians and researchers who work on the development and implementation of assisted reproductive biotechnologies in Mexico, and to develop existing relationships with Mexican academics who work on the ethical and legal issues surrounding assisted reproductive biotechnologies.
More specifically, one of the objectives of this project is set to develop a relationship with physicians and researchers who work at Mexico’s National Institute of Perinatology. This institute is the main research and academic hub for reproductive medicine in Mexico. The collaboration will focus on three areas: conscientious objection and its relationship with reproductive medicine; the ethics of reproductive biotechnologies that alter the DNA of embryos or gametes; and the ethical issues of uterus transplants.